Total Payments
$165,986
2024 Payments
$44,419
Companies
14
Transactions
133
Medicare Patients
689
Medicare Billing
$66,719
Payment Breakdown by Category
Other$162,400 (97.8%)
Food & Beverage$3,586 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $162,400 | 7 | 97.8% |
| Food and Beverage | $3,586 | 126 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $162,900 | 20 | $0 (2024) |
| GENZYME CORPORATION | $856.69 | 26 | $0 (2024) |
| ABBVIE INC. | $773.47 | 44 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $539.47 | 18 | $0 (2024) |
| Lilly USA, LLC | $243.54 | 5 | $0 (2022) |
| Amgen Inc. | $172.08 | 5 | $0 (2021) |
| Stryker Corporation | $161.11 | 1 | $0 (2022) |
| Merz North America, Inc. | $155.10 | 4 | $0 (2023) |
| Incyte Corporation | $61.47 | 3 | $0 (2024) |
| PFIZER INC. | $46.30 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,419 | 59 | Galderma Laboratories, L.P. ($43,425) |
| 2023 | $104,448 | 37 | Galderma Laboratories, L.P. ($103,456) |
| 2022 | $16,575 | 18 | Galderma Laboratories, L.P. ($16,019) |
| 2021 | $343.83 | 12 | AbbVie Inc. ($208.53) |
| 2020 | $200.98 | 7 | Amgen Inc. ($157.19) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.59 | General |
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.79 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.33 | General |
| 11/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $8.84 | General |
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.29 | General |
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.83 | General |
| 10/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $169.49 | General |
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $163.98 | General |
| 09/25/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $43,000.00 | General |
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.43 | General |
| 09/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Immunology | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: DERMATOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 657 | 1,154 | $138,853 | $63,086 |
| 2022 | 2 | 32 | 32 | $7,137 | $3,633 |
Total Patients
689
Total Services
1,186
Medicare Billing
$66,719
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 152 | 152 | $28,558 | $11,903 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 137 | $20,524 | $10,260 | 50.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 67 | 90 | $17,890 | $8,837 | 49.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 89 | 101 | $17,902 | $7,538 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $15,318 | $6,777 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 46 | $9,712 | $4,621 | 47.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 71 | 107 | $12,334 | $4,606 | 37.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $6,303 | $3,294 | 52.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 58 | 390 | $4,582 | $2,320 | 50.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 24 | 49 | $4,277 | $2,236 | 52.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 14 | $1,454 | $693.70 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,595 | $1,879 | 52.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,542 | $1,754 | 49.5% |
About Dr. Christopher Tomassian, MD
Dr. Christopher Tomassian, MD is a Procedural Dermatology healthcare provider based in Glendora, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2018. The National Provider Identifier (NPI) number assigned to this provider is 1871097550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Tomassian, MD has received a total of $165,986 in payments from pharmaceutical and medical device companies, with $44,419 received in 2024. These payments were reported across 133 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($162,400).
As a Medicare-enrolled provider, Tomassian has provided services to 689 Medicare beneficiaries, totaling 1,186 services with total Medicare billing of $66,719. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Dermatology
- Location Glendora, CA
- Active Since 03/19/2018
- Last Updated 08/24/2022
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1871097550
Products in Payments
- DUPIXENT (Biological) $1,396
- SKYRIZI (Biological) $315.85
- RINVOQ (Biological) $256.28
- Otezla (Drug) $172.08
- MAKO (Device) $161.11
- Xeomin (Biological) $108.16
- OPZELURA (Drug) $61.47
- BOTOX (Biological) $54.86
- EUCRISA (Drug) $46.30
- TALTZ (Drug) $40.90
- HUMIRA (Biological) $30.91
- COSENTYX (Drug) $18.19
- ADBRY (Biological) $18.17
- VALCHLOR (Drug) $11.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.